Search Results - Dario Reichenstein

  • Showing 1 - 1 results of 1
Refine Results
  1. 1

    ANV600 is a novel PD-1 targeted IL-2Rβγ agonist that selectively expands tumor antigen-specific T cells and potentiates PD-1 checkpoint inhibitor therapy by Christoph Huber, Christian Stocker, Patrizia Murer, Ulisse Salazar, Nicole Egli, Laetitia Petersen, Pia Neubert, Alexander Rau, Andreas Katopodis, Anais Zurbach, Dario Reichenstein

    Published in Journal for ImmunoTherapy of Cancer (2025-07-01)
    Get full text
    Article


Search Tools: